Tempus AI ROA 2023-2025 | TEM
Current and historical return on assets (ROA) values for Tempus AI (TEM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Tempus AI ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.72B | $1.54B | -66.98% |
| 2024-12-31 | $-0.75B | $0.93B | -92.33% |
| 2024-09-30 | $-0.78B | $0.97B | -109.13% |
| 2024-06-30 | $-0.77B | $0.87B | -162.70% |
| 2024-03-31 | $-0.28B | $0.47B | -106.49% |
| 2023-12-31 | $-0.25B | $0.56B | -175.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.232B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.424B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |